Atlas Trials

Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Complications in Diabetic Patients

Clinical trial NCT04430660 · COMPLETED

Trial details

NCT number
NCT04430660
Sponsor
Pennington Biomedical Research Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
DiabetesHypoglycemia
Start date
2020-08-19
Primary completion
2022-03-29
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.